As of January 22, 2025, Rocket Pharmaceuticals (RCKT) has a market cap of $1.11 billion USD. According to our data, Rocket Pharmaceuticals is ranked No.5060 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.11 B |
-16.97%
|
Dec 31, 2024 | $1.34 B |
-58.06%
|
Dec 29, 2023 | $3.19 B |
53.14%
|
Dec 30, 2022 | $2.08 B |
-10.35%
|
Dec 31, 2021 | $2.32 B |
-60.19%
|
Dec 31, 2020 | $5.83 B |
140.95%
|
Dec 31, 2019 | $2.42 B |
53.58%
|
Dec 31, 2018 | $1.58 B |
41.95%
|
Dec 29, 2017 | $1.11 B |
-57.21%
|
Dec 30, 2016 | $2.59 B |
-46.16%
|
Dec 31, 2015 | $4.82 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.11 B |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.38 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Passage Bio
PASG
|
$37.24 M |
0.000 M
|
USA
|
Adverum Biotechnologies
ADVM
|
$93.20 M |
0.000 M
|
USA
|
uniQure
QURE
|
$0.81 B |
0.000 M
|
Netherlands
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Generation Bio
GBIO
|
$63.79 M |
0.000 M
|
USA
|
Market Cap | = | RCKT Stock Price | * | RCKT Shares Outstanding |
= | $10.44 | * | 0.11 B | |
= | $1.11 B |